Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima.
暂无分享,去创建一个
Ruth Nussinov | Chung-Jung Tsai | Chava Kimchi-Sarfaty | Zuben E Sauna | Michael M Gottesman | R. Nussinov | Chung-Jung Tsai | M. Gottesman | C. Kimchi-Sarfaty | Z. Sauna | S. Ambudkar | Suresh V Ambudkar
[1] R. Kopito,et al. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. , 1994, The Journal of biological chemistry.
[2] C. Kurland,et al. Codon usage determines translation rate in Escherichia coli. , 1989, Journal of molecular biology.
[3] Ricardo Ehrlich,et al. Silent mutations affect in vivo protein folding in Escherichia coli. , 2002, Biochemical and biophysical research communications.
[4] R. Nussinov,et al. The building block folding model and the kinetics of protein folding. , 2001, Protein engineering.
[5] I. Ivanov,et al. Unusual effect of clusters of rare arginine (AGG) codons on the expression of human interferon alpha 1 gene in Escherichia coli. , 1997, The international journal of biochemistry & cell biology.
[6] J. Clarke,et al. Apparent cooperativity in the folding of multidomain proteins depends on the relative rates of folding of the constituent domains , 2006, Proceedings of the National Academy of Sciences.
[7] Kai Du,et al. The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR , 2005, Nature Structural &Molecular Biology.
[8] R. Nussinov,et al. Molecular dynamics simulations of alanine rich β‐sheet oligomers: Insight into amyloid formation , 2002, Protein science : a publication of the Protein Society.
[9] A. Parente,et al. The dual-mode quaternary structure of seminal RNase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Ramachandra,et al. Functional Characterization of Glycosylation-Deficient Human P-Glycoprotein Using A Vaccinia Virus Expression System , 2000, The Journal of Membrane Biology.
[11] I. Braakman,et al. Folding of CFTR is predominantly cotranslational. , 2005, Molecular cell.
[12] G. D'alessio. Oligomer evolution in action? , 1995, Nature Structural Biology.
[13] D. Agard,et al. Protease pro region required for folding is a potent inhibitor of the mature enzyme , 1992, Proteins.
[14] L. Hurst,et al. Hearing silence: non-neutral evolution at synonymous sites in mammals , 2006, Nature Reviews Genetics.
[15] A. Spirin,et al. Cotranslational Folding of Globin* , 1997, The Journal of Biological Chemistry.
[16] J. Weinstein,et al. The folding of ovalbumin. Renaturation in vitro versus biosynthesis in vitro. , 1983, The Biochemical journal.
[17] M. Schumacher,et al. Structural mechanism of the simultaneous binding of two drugs to a multidrug‐binding protein , 2004, The EMBO journal.
[18] J. Brodsky,et al. The activities and function of molecular chaperones in the endoplasmic reticulum. , 2007, Seminars in cell & developmental biology.
[19] Z. Poljaković,et al. Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment , 2006, Epilepsia.
[20] W. Młynarski,et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia , 2004, European journal of haematology.
[21] K. Dill,et al. From Levinthal to pathways to funnels , 1997, Nature Structural Biology.
[22] Jeffrey L Brodsky,et al. The Recognition and Retrotranslocation of Misfolded Proteins from the Endoplasmic Reticulum , 2008, Traffic.
[23] J. Onuchic,et al. Navigating the folding routes , 1995, Science.
[24] S. Parvez,et al. Conformational toxicity and sporadic conformational diseases. , 2000, Toxicology.
[25] S Grinstein,et al. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. , 1994, The EMBO journal.
[26] M. Gottesman,et al. Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.
[27] R Nussinov,et al. Binding and folding: in search of intramolecular chaperone-like building block fragments. , 2000, Protein engineering.
[28] M. Schumacher,et al. Structural Mechanisms of QacR Induction and Multidrug Recognition , 2001, Science.
[29] M. Sørensen,et al. Absolute in vivo translation rates of individual codons in Escherichia coli. The two glutamic acid codons GAA and GAG are translated with a threefold difference in rate. , 1991, Journal of molecular biology.
[30] A. Komar,et al. Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation , 1999, FEBS letters.
[31] R. Kreienberg,et al. Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. , 2003, International journal of oncology.
[32] C. Anfinsen. Principles that govern the folding of protein chains. , 1973, Science.
[33] Hiroshi Akashi,et al. Translational selection and yeast proteome evolution. , 2003, Genetics.
[34] A. Brown,et al. The efficiency of folding of some proteins is increased by controlled rates of translation in vivo. A hypothesis. , 1987, Journal of molecular biology.
[35] J. Wakefield,et al. Efficient Intracellular Processing of the Endogenous Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cell Lines* , 2004, Journal of Biological Chemistry.
[36] I. Pastan,et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.
[37] R. Nussinov,et al. Folding funnels and binding mechanisms. , 1999, Protein engineering.
[38] P. Lansbury,et al. Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.
[39] E. Shakhnovich,et al. The role of cotranslation in protein folding: a lattice model study , 2004 .
[40] K. M. Routzahn,et al. Maltodextrin‐binding proteins from diverse bacteria and archaea are potent solubility enhancers , 2003, FEBS letters.
[41] D. Eisenberg,et al. Domain swapping: entangling alliances between proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Brown,et al. Protein folding within the cell is influenced by controlled rates of polypeptide elongation. , 1992, Journal of molecular biology.
[43] W. Weimar,et al. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR‐1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus , 2003, Clinical pharmacology and therapeutics.
[44] Lippincott-Schwartz,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .
[45] S. Markova,et al. Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation. , 2006, Drug metabolism and pharmacokinetics.
[46] D. Danley,et al. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1. , 1990, Biochimica et biophysica acta.
[47] R. Dawson,et al. Structure of a bacterial multidrug ABC transporter , 2006, Nature.
[48] M. Schumacher,et al. Structural basis for cooperative DNA binding by two dimers of the multidrug‐binding protein QacR , 2002, The EMBO journal.
[49] F. Hartl,et al. Recombination of protein domains facilitated by co-translational folding in eukaryotes , 1997, Nature.
[50] P Argos,et al. Protein secondary structural types are differentially coded on messenger RNA , 1996, Protein science : a publication of the Protein Society.
[51] M. Inouye,et al. Protein memory through altered folding mediated by intramolecular chaperones , 1997, Nature.
[52] M. Brodie,et al. Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment , 2005, Epilepsia.
[53] M. Inouye,et al. The structural and functional organization of intramolecular chaperones: the N-terminal propeptides which mediate protein folding. , 1994, Journal of biochemistry.
[54] C. Kurland,et al. Co-variation of tRNA abundance and codon usage in Escherichia coli at different growth rates. , 1996, Journal of molecular biology.
[55] D. Baker,et al. Contact order, transition state placement and the refolding rates of single domain proteins. , 1998, Journal of molecular biology.
[56] L. Duret,et al. Expression pattern and, surprisingly, gene length shape codon usage in Caenorhabditis, Drosophila, and Arabidopsis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Nussinov,et al. Folding funnels, binding funnels, and protein function , 1999, Protein science : a publication of the Protein Society.
[58] T. Rapoport,et al. Retro-translocation of proteins from the endoplasmic reticulum into the cytosol , 2002, Nature Reviews Molecular Cell Biology.
[59] B. Machaliński,et al. Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. , 2005, European journal of pharmacology.
[60] D. Roden,et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.
[61] R. B. Dyer,et al. Ultrafast and downhill protein folding. , 2007, Current opinion in structural biology.
[62] Patricia L Clark,et al. Protein folding in the cell: reshaping the folding funnel. , 2004, Trends in biochemical sciences.
[63] M. Schumacher,et al. Crystal Structures of QacR-Diamidine Complexes Reveal Additional Multidrug-binding Modes and a Novel Mechanism of Drug Charge Neutralization* , 2004, Journal of Biological Chemistry.
[64] V. Lyakhovich,et al. Possible Prediction of the Efficiency of Chemotherapy in Patients with Lymphoproliferative Diseases Based on MDR1 Gene G2677T and C3435T Polymorphisms , 2003, Bulletin of Experimental Biology and Medicine.
[65] P. Sonneveld,et al. MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. , 2001, Blood.
[66] Y. Teo,et al. Effect of MDR1 haplotype on risk of Parkinson disease. , 2005, Archives of neurology.
[67] M. Schumacher,et al. Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR. , 2003, Research in microbiology.
[68] P. Clark,et al. Conformations of co-translational folding intermediates. , 2005, Protein and peptide letters.
[69] R. Nussinov,et al. Anatomy of protein structures: visualizing how a one-dimensional protein chain folds into a three-dimensional shape. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[70] G. von Heijne,et al. Do protein-lipid interactions determine the recognition of transmembrane helices at the ER translocon? , 2005, Biochemical Society transactions.
[71] Gerry McDermott,et al. Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump , 2003, Science.
[72] Christopher M Dobson,et al. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.
[73] R. Nussinov,et al. Folding and binding cascades: Dynamic landscapes and population shifts , 2008, Protein science : a publication of the Protein Society.
[74] R. Nussinov,et al. Folding and binding cascades: shifts in energy landscapes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[75] R. Nussinov,et al. Distinguishing between sequential and nonsequentially folded proteins: Implications for folding and misfolding , 1999, Protein science : a publication of the Protein Society.
[76] M. Gottesman,et al. Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.
[77] M Yarus,et al. Rates of aminoacyl-tRNA selection at 29 sense codons in vivo. , 1989, Journal of molecular biology.
[78] W. Sugiura,et al. Influence of Single-Nucleotide Polymorphisms in the Multidrug Resistance-1 Gene on the Cellular Export of Nelfinavir and Its Clinical Implication for Highly Active Antiretroviral Therapy , 2004, Antiviral therapy.
[79] Charlotte M. Deane,et al. Modelling sequential protein folding under kinetic control , 2006, ISMB.
[80] D. Clarke,et al. The Minimum Functional Unit of Human P-glycoprotein Appears to be a Monomer* , 1996, The Journal of Biological Chemistry.
[81] A. Brown,et al. The folding of the bifunctional TRP3 protein in yeast is influenced by a translational pause which lies in a region of structural divergence with Escherichia coli indoleglycerol-phosphate synthase. , 1994, European journal of biochemistry.
[82] A Helenius,et al. How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. , 1994, Molecular biology of the cell.
[83] Ozlem Keskin,et al. Similar binding sites and different partners: implications to shared proteins in cellular pathways. , 2007, Structure.
[84] D Eisenberg,et al. 3D domain swapping: A mechanism for oligomer assembly , 1995, Protein science : a publication of the Protein Society.
[85] P Argos,et al. Ribosome‐mediated translational pause and protein domain organization , 1996, Protein science : a publication of the Protein Society.